Welcome
(I'm not )
Home
My Settings
Help
Log Out
Select a date:
February 20, 2019
February 19, 2019
February 18, 2019
February 17, 2019
February 16, 2019
February 15, 2019
February 14, 2019
February 13, 2019
February 12, 2019
February 11, 2019
February 10, 2019
February 9, 2019
February 8, 2019
February 7, 2019
February 6, 2019
February 5, 2019
February 4, 2019
February 3, 2019
February 2, 2019
February 1, 2019
January 31, 2019
January 30, 2019
January 29, 2019
January 28, 2019
January 27, 2019
January 26, 2019
January 25, 2019
January 24, 2019
January 23, 2019
January 22, 2019
Click here to add topics
Click here to add companies
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
No top stories
Financial Services & Investing
Stock Market
Alternative Energy
Aerospace & Defense
Telecom News
Government
Managed Health Care
Natural Disaster
Economic Indicators
Internet Media, Content & Design
Infectious Disease
Researchers find trigger that turns strep infections into flesh-eating disease
Houston Methodist infectious disease scientists have discovered a previously unknown trigger that turns a relatively run-of-the-mill infection into a devastatingly ravenous, flesh-eating disease.</p> Group A streptococcus is an organism that...
Contify, 9:58am ET
Respiratory Protective Equipment Market growing at 7.2% CAGR growth up to 2024
Extensive R&D in medical & healthcare sector across North America present promising growth aspects for regional respiratory protective equipment market. Also, severe legislations regarding safety measures by World Health Organization...
Heraldkeeper, 9:13am ET
Alcon Debuts iLux MGD Treatment System for Personalized Therapy for Dry Eye Disease at SECO International 2019 Annual Meeting
NEW ORLEANS, Feb. 19 -- Alcon issued the following news release: - Innovative treatment system for Meibomian Gland Dysfunction (MGD) headlines robust Alcon meeting program - New data presentations reinforce the impact of Alcon's...
Contify, 9:08am ET
Pulmatrix Reports 2018 Financial Results; Provides 2019 Outlook on Pulmonary Disease Pipeline
Lexington, Massachusetts, Feb. 19 -- Pulmatrix issued the following news release: Pulmatrix, Inc. (NASDAQ: PULM) today announces 2018 financial results, reviews the Company's recent progress, and provides an outlook for its pulmonary...
Contify, 9:08am ET
Cumberland Pharmaceuticals To Announce Fourth Quarter And Annual 2018 Financial Results
NASHVILLE, Tennessee, Feb. 19 -- Cumberland Pharmaceuticals Inc. issued the following news release: Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) announced today that it will release fourth quarter and annual 2018 financial results after...
Contify, 9:03am ET
Blockchain Healthcare App IFFY Helps Online Dating Users Verify Partner's Health
IFFY, a blockchain-based application, today announced the launch of their decentralized healthcare record-keeping platform. Users can privately and securely store their medical records on the platform, and grant access to STD test results via...
ABNewswire, 8:53am ET
Spring Bank Pharmaceuticals Appoints Atif Abbas, M.D., as Vice President, Head of Oncology & Immunology Clinical Development
HOPKINTON, Massachusetts, Feb. 19 -- Spring Bank Pharmaceuticals issued the following news release: Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the...
Contify, 8:48am ET
RedHill Biopharma Strengthens Management Team with Appointment of Rick D. Scruggs as Chief Operating Officer, U.S. Operations
RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company primarily focused on proprietary drugs for gastrointestinal (GI) diseases, today announced that it has...
GlobeNewswire, 8:39am ET
Amyloidosis Treatment Market In- depth Analysis & Recent Developments, (2019-2025)
“Global Amyloidosis Treatment Market (By Types, By Applications, By Leading Regions and Crucial Players) by Crystal Market Research– Segments Outlook, Business Assessment, Competition Scenario, Trends and Forecast 2019-2025” investigations...
Heraldkeeper, 8:33am ET
Inovio Announces First Subject Dosed with its DNA-Encoded Monoclonal Antibody (dMAb(TM)) In First-Ever Human Trial
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) in collaboration with The Wistar Institute and the University of Pennsylvania announced today that the first subject was dosed as part of the first-ever human study of Inovio's DNA-encoded monoclonal...
PR Newswire, 8:08am ET
Abbott Introduces the World's Most Sensitive Rapid Diagnostic Test, Determine(TM) HBsAg 2, to Accelerate Hepatitis B Care
Abbott (NYSE: ABT) announced today it has received CE Mark for the world's most sensitive rapid diagnostic test for the detection of hepatitis B surface antigen, the Determine(TM) HBsAg 2 test for use with serum, plasma or whole blood.1,2,3 This...
PR Newswire, 8:08am ET
AbbVie's HUMIRA® (Adalimumab) Approved by Health Canada to Treat Pediatric Patients with Chronic Non-infectious Anterior Uveitis
-- The approval marks HUMIRA as the only approved biologic treatment option in Canada for pediatric patients from two years of age with chronic non-infectious anterior uveitis who have had inadequate response to conventional.
CNW Group, 8:08am ET
Insmed to Present at the Leerink Partners 8th Annual Global Healthcare Conference
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chief Executive Officer of Insmed, will present at...
PR Newswire, 8:08am ET
Abbott Introduces the World's Most Sensitive Rapid Diagnostic Test, Determine(TM) HBsAg 2, to Accelerate Hepatitis B Care
- New point-of-care rapid test identifies and helps make effective care more accessible for millions of people living with hepatitis B, in support of World Health Organization (WHO) hepatitis targets - Life-changing test has obtained...
PR Newswire Europe, 8:08am ET
FDA agrees to review AbbVie's upadacitinib in rheumatoid arthritis
The US Food and Drug Administration (FDA) has accepted a new drug application (NDA) submitted by AbbVie for its investigational medicine upadacitinib to treat adults with moderate to severe rheumatoid arthritis. The regulatory agency has...
MarketLine, 7:58am ET
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease
Mallinckrodt Pharmaceuticals (NYSE:MNK), a leading global specialty pharmaceutical company, today announced interim analysis results of its company-sponsored, Phase 3, single-arm, open-label, multi-center study assessing the efficacy of treating...
PR Newswire, 7:43am ET
Generic Oncology Drugs Market is Poised to Surpass a Stunning CAGR of 6.2% Through 2028 - Future Market Insights
Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of...
PR Newswire Europe, 7:43am ET
Generic Oncology Drugs Market is Poised to Surpass a Stunning CAGR of 6.2% Through 2028 - Future Market Insights
Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer. Notable enhancements in the technology with the blend of information is expected to accelerate the pace of...
PR Newswire, 7:43am ET
Opinion: The stigma against queer sex education is dangerous
There's no question that sex education has always been awkward. Most of us remember when we learned about the reproductive system, "the birds and the bees." As uncomfortable as that may be, early on we are taught the importance of...
University Wire, 7:28am ET
At 13.9% CAGR Microsurgery Robot Market to hit USD 1.7 bn by 2024
The Microsurgery robot Market to exceed USD 1.7 billion by 2024; according to a new research report by Global Market Insights. Increasing demand for minimally invasive surgical procedure will remarkably drive microsurgery robot market growth over...
Heraldkeeper, 7:23am ET
1-20 of 296
Next 20 >>
Home
Help
My Settings
Privacy Policy
Terms of Service
Advertising
About Us
Contact Us
Logout
Copyright 1995-, Individual.com. No redistribution allowed.
